Please try another search
Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett’s esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
Name | Age | Since | Title |
---|---|---|---|
Derek J. Maetzold | 59 | 2007 | Founder, CEO, President & Director |
Mara Glickman Aspinall | 59 | 2015 | Independent Director |
Daniel Mark Bradbury | 60 | 2012 | Independent Chairman of the Board |
G. Bradley Cole | 65 | 2018 | Independent Director |
Howard Colman | - | - | Member of Scientific Advisory Board |
Kenneth D. Aldape | - | - | Member of Scientific Advisory Board |
Miles D. Harrison | 56 | 2020 | Independent Director |
Tiffany P. Olson | 63 | 2021 | Independent Director |
Ellen Goldberg | 47 | 2021 | Independent Director |
Kimberlee Caple | 60 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review